Resources

Publications

05/20/2021
- Oncology
Comprehensive Genomic and Transcriptomic Profiling of Pediatric Malignancies Using the Tempus xT Next-Generation Sequencing Assay to Identify Clinically Meaningful Alterations
ASCO Annual Meeting 2021
05/20/2021
- Oncology
Multimodal Profiling of Biliary Tract Cancers to Detect Potentially Actionable Biomarkers and Differences in Immune Signatures Between Subtypes
ASCO Annual Meeting 2021
05/20/2021
- Oncology
A Review of Evidence Supporting NCCN Category 2B Off-label Recommendations for Determination of Medicare Reimbursement Eligibility
ASCO Annual Meeting 2021
05/20/2021
- Oncology
Rate of Incidental Germline Findings Detected by Tumor-Normal Matched Sequencing in Cancer Types Lacking Hereditary Cancer Testing Guidelines
ASCO Annual Meeting 2021
05/20/2021
- Oncology
The TIME Trial Network to Facilitate Rapid Clinical Trial Activation, Patient Screening, and Enrollment in Molecularly Targeted Trials
ASCO Annual Meeting 2021
05/20/2021
- Oncology
Landscape of KRASG12C, Associated Genomic Alterations, and Interrelation With Immuno-Oncology (IO) Biomarkers
ASCO Annual Meeting 2021
05/07/2021
- Infectious Disease
Multiplex qPCR Discriminates Variants of Concern to Enhance Global Surveillance of SARS-CoV-2
PLOS Biology
04/30/2021
- Oncology
BloodPAC Data Commons for Liquid Biopsy Data
JCO Clinical Cancer Informatics
04/14/2021
- Oncology
Novel Targetable FGFR2 and FGFR3 Alterations in Glioblastoma Associate With Aggressive Phenotype and Distinct Gene Expression Programs
Acta Neuropathologica Communications
04/13/2021
- Oncology
Synthetic Lethality-Mediated Precision Oncology via the Tumor Transcriptome
Cell

56 57 58